Related Experiment Video
Updated: Jun 26, 2026

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
Eukaryotic initiation factors (eIF) 2alpha and 4E expression, localization, and phosphorylation in brain tumors
Sonia Tejada1, M Val T Lobo, Mercedes García-Villanueva
1Servicio de Neurocirugía, Hospital Ramón y Cajal, Ctra. Colmenar Km. 9, 28034 Madrid, Spain.
Abstract:
Increased protein synthesis is regulated, in part, by two eukaryotic translation initiation factors (eIFs): eIF4E and eIF2alpha. One or both of these factors are often overexpressed in several types of cancer cells; however, no data are available at present regarding eIF4E and eIF2alpha levels in brain tumors. In this study, we analyzed the expression, subcellular localization and phosphorylation states of eIF4E and eIF2alpha in 64 brain tumors (26 meningiomas, 16 oligodendroglial tumors, and 22 astrocytomas) and investigated the correlation with the expression of MIB-1, p53, and cyclin D1 proteins as well. There are significant differences in the phosphorylated eIF4E levels between the tumors studied, being the highest in meningiomas and the lowest in the oligodendroglial tumors. Relative to subcellular localization, eIF4E is frequently found in the nucleus of the oligodendroglial tumors and rarely in the same compartment of the meningiomas, whereas eIF2alpha showed an inverse pattern. Finally, cyclin D1 levels directly correlate with the phosphorylation status of both factors. The different expression, phosphorylation, or/and subcellular distribution of eIF2alpha and eIF4E within the brain types of tumors studied could indicate that different pathways are activated for promoting cell cycle proliferation, for instance, leading to increased cyclin D1 expression.
Insights
Levels of eukaryotic translation initiation factors (eIFs) like eIF4E and eIF2alpha vary in brain tumors. Their altered expression and localization correlate with cell proliferation markers, suggesting distinct pathways in tumor growth.
Area of Science:
- Molecular Biology
- Oncology
- Neuroscience
Background:
- Protein synthesis is crucial for cell growth and is regulated by eukaryotic translation initiation factors (eIFs).
- eIF4E and eIF2alpha are key eIFs often overexpressed in various cancers.
- Data on eIF4E and eIF2alpha in brain tumors were previously lacking.
Purpose of the Study:
- To analyze the expression, subcellular localization, and phosphorylation of eIF4E and eIF2alpha in different brain tumor types.
- To investigate the correlation between eIF4E/eIF2alpha and MIB-1, p53, and cyclin D1 protein expression.
- To understand the role of these factors in brain tumor proliferation.
Main Methods:
- Analysis of eIF4E and eIF2alpha expression, localization, and phosphorylation in 64 brain tumors (meningiomas, oligodendroglial tumors, astrocytomas).
- Assessment of MIB-1, p53, and cyclin D1 protein levels.
- Statistical analysis to determine correlations.
Main Results:
- Significant differences in phosphorylated eIF4E levels were observed, highest in meningiomas and lowest in oligodendroglial tumors.
- eIF4E predominantly localized to the nucleus in oligodendroglial tumors, while eIF2alpha showed an inverse pattern.
- Cyclin D1 levels directly correlated with the phosphorylation status of both eIF4E and eIF2alpha.
Conclusions:
- Differential expression, phosphorylation, and subcellular distribution of eIF4E and eIF2alpha suggest distinct activation pathways in brain tumors.
- These pathways may contribute to increased cyclin D1 expression and cell cycle proliferation.
- Findings highlight the potential involvement of these eIFs in brain tumor pathogenesis.
Related Concept Videos
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Regulated mRNA Transport
Regulation of Angiogenesis and Blood Supply
General Transcription Factors
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

